Skip to main content

Table 5 Analysis of tumour volumes detected via 7 T in vivo MRI in a CT1258 based in vivo model of prostate cancer

From: Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer

Animal Day 23; Day 25; Day 39; Day 47;
Tumour volume [mm3] Tumour volume [mm3] Tumour volume [mm3] Tumour volume [mm3]
10 5.16 10.76 420.45  
(♀, intact)     
11   1.33 1.18 3.60
(♀, intact)     
12 8.73 12.3 271.19  
(♀, OHM)     
13 19.48 29.75 148.65  
(♀, OHM)     
  1. The female animals received 103 MnCl2 CT1258 labelled cells. The tumour volumes are displayed for the respective days of MRI measurements after subcutaneous injection.
  2. ♀ = female animal; OHM = Ovariohysterectomised.
\